Citranatal Dha
Product Images NDC 0178-0894

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Citranatal Dha (NDC 0178-0894). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mission Pharmacal Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Citra-natal-dha-carton-0178-0894-30 (Citra Natal Dha Carton 0178 0894 30)

FDA Label Image

Citranatal Dha (Blisters)

Citranatal Dha (Blisters)
CITRANATAL® RX is a tablet distributed by Mission Pharmacal Company in San Antonio, TX. It appears to be a medication for individuals with a bleeding disorder. The product has a LOT number. The label warns of accidental overdosing and advises to keep the product out of reach of children. The label instructs individuals to immediately contact a doctor or poison control center if ingested accidentally. Additionally, there are some illegible characters and fragments, so there may be additional warnings or instructions that are not visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.